Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi, GÜLEN; Meara, Alexa; Ozguler, YEŞİM; Direskeneli, Haner; Mahr, Alfred; Easley, Ebony; Gurcan, Mert; Davis, Trocon; Gül, Ahmet; Yazici, Yusuf; ZOTTENBERG, Katelyn; Esatoglu, SİNEM; Erer, Burak; Kamali, Sevil; Yazici, Hasan; Cronholm, Peter; Merkel, Peter

doi:10.3899/jrheum.161352

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., ...Daha Fazla

The Journal of rheumatology, cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44 Sayı: 11
Basım Tarihi: 2017
Doi Numarası: 10.3899/jrheum.161352
Dergi Adı: The Journal of rheumatology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1750-1753
Anahtar Kelimeler: BEHCET DISEASE, OUTCOMES, OUTCOME MEASURES, OUTCOME ASSESSMENT, OMERACT, CONSTANT COMPARATIVE METHOD, CLINICAL-TRIALS
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group has been working toward developing a data-driven core set of outcome measures for use in clinical trials of Behcet's syndrome [Behcet disease (BD)]. This paper summarizes the group's work through OMERACT 2016, discussions during the meeting, and the future research agenda.